Press Releases

Date	Title	Company
13-Jul-2021	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC	Immutep
13-Jul-2021	F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors	F-star Therapeutics
13-Jul-2021	Global Homozygous Familial Hypercholesterolemia Clinical Trials Review - H1, 2021 - ResearchAndMarkets.com	Businesswire
13-Jul-2021	FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial	Businesswire
13-Jul-2021	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
13-Jul-2021	Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases	Muna Therapeutics
13-Jul-2021	New blood test for the diagnostics of frontotemporal dementia	University of Eastern Finland
13-Jul-2021	Global Fc Fusion Protein for Haemophilia Market Feasibility Analysis, Application, Growing Trends and Forecast 2021-2026	CDN Newswire
13-Jul-2021	Induction Healthcare and Attend Anywhere join forces to increase flexible care options for hospitals and patients	Induction Healthcare
13-Jul-2021	RDIF and Serum Institute of India, the world’s largest vaccine manufacturer by volume, to start production of Sputnik vaccine at Company’s facilities in September	Russian Direct Investment Fund
13-Jul-2021	Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain	Ultragenyx
13-Jul-2021	The Scottish Medicines Consortium recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)	Novartis
13-Jul-2021	Global Alprolix Market Research Status, Business Growth Analysis by Top Countries Data, Segments Insights 2021-2026	CDN Newswire
13-Jul-2021	Sputnik V vaccine effective against new variants of coronavirus, the Gamaleya Center study published in Vaccines leading international journal, shows	Russian Direct Investment Fund
13-Jul-2021	Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway	Panthera
13-Jul-2021	Enterome announces first patient dosed in a Phase 1/2 trial with second OncoMimicsTM vaccine, EO2463, in non-Hodgkin lymphoma	ENTEROME SA
13-Jul-2021	Sputnik V vaccine elicits high IGG antibodies and neutralizing antibodies titers, a study in Argentina published in international Cell Reports Medicine journal shows	Russian Direct Investment Fund
13-Jul-2021	SmiLe launches BioTech program with German BioM and Merck	SmiLe
13-Jul-2021	Sputnik V vaccine demonstrates strong safety profile during vaccination campaign in San Marino	Russian Direct Investment Fund
13-Jul-2021	F-star Therapeutics to Present at Upcoming Investor Conferences	F-star Therapeutics